Midwifery · 2025
Prioritisation of where and when to initiate a lifestyle intervention to reduce cardiometabolic disease risk in high-risk pregnant and postpartum women: A pre-implementation mixed-methods study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Osei-Safo Elaine K, Melder Angela, Taylor Frances, Slater Kaylee, Hutchesson Melinda, Reddy Anjana, Cowan Stephanie, Moran Lisa, Lang Sarah
Аннотация
BACKGROUND: Experiencing gestational diabetes mellitus (GDM), hypertensive disorders of pregnancy (HDP), intrauterine growth restriction (IUGR) and preterm birth (PTB) increases women's risk of future type 2 diabetes and cardiovascular disease. Pregnancy and postpartum present ideal opportunities to intervene through lifestyle management and risk awareness to prevent or delay the onset of cardiometabolic pregnancy complications and future cardiometabolic disease. Designing interventions aligning with the needs and priorities of stakeholders is a critical first step in developing acceptable interventions.
AIMS: To explore stakeholder perspectives and prioritise the optimal timing and setting to deliver a lifestyle intervention to improve cardiometabolic health amongst women high-risk for or diagnosed with a cardiometabolic pregnancy complication.
METHODS: A pre-implementation study using an embedded mixed-methods research design. Facilitator-led workshops were used to prioritise the preferred timing (pregnancy or postpartum) and setting (hospital, primary healthcare, community health program, maternal and child health nurse appointments or online) for an intervention.
FINDINGS: Women with prior GDM, HDP, IUGR and/or PTB (n = 9), and research partners (n = 15) (obstetricians, endocrinologists, community health representatives, researchers, a midwife, general practitioner and dietitian) participated. The findings suggest developing a lifestyle intervention for women commencing during pregnancy (in the hospital) and continuing into postpartum (online) should be considered.
CONCLUSION: Stakeholders prioritised a pregnancy and postpartum intervention delivered via hospital antenatal care and online. Commencing interventions during pregnancy and continuing into postpartum will likely support continuity of care and improve health outcomes across both life stages. Early stakeholder engagement supports the development of acceptable, tailored interventions, for translation into real-world healthcare settings.
AIMS: To explore stakeholder perspectives and prioritise the optimal timing and setting to deliver a lifestyle intervention to improve cardiometabolic health amongst women high-risk for or diagnosed with a cardiometabolic pregnancy complication.
METHODS: A pre-implementation study using an embedded mixed-methods research design. Facilitator-led workshops were used to prioritise the preferred timing (pregnancy or postpartum) and setting (hospital, primary healthcare, community health program, maternal and child health nurse appointments or online) for an intervention.
FINDINGS: Women with prior GDM, HDP, IUGR and/or PTB (n = 9), and research partners (n = 15) (obstetricians, endocrinologists, community health representatives, researchers, a midwife, general practitioner and dietitian) participated. The findings suggest developing a lifestyle intervention for women commencing during pregnancy (in the hospital) and continuing into postpartum (online) should be considered.
CONCLUSION: Stakeholders prioritised a pregnancy and postpartum intervention delivered via hospital antenatal care and online. Commencing interventions during pregnancy and continuing into postpartum will likely support continuity of care and improve health outcomes across both life stages. Early stakeholder engagement supports the development of acceptable, tailored interventions, for translation into real-world healthcare settings.